Funded Health Care Startups in Denmark
Across these 20 recently dated Denmark health care rounds, the single largest disclosed amount is Orbis Medicines’ $93M Series A on 2025-01-06, and it clea…
Across these 20 recently dated Denmark health care rounds, the single largest disclosed amount is Orbis Medicines’ $93M Series A on 2025-01-06, and it clearly dwarfs the next-largest disclosed rounds in the table (Cercare Medical at $8M on 2025-02-19, CathVision at $9M on 2023-07-18, Dawn Health at $13M on 2025-05-05, and Woba at $3M on 2023-09-01). At the low end, the only clearly tiny disclosed figure is Brain+’s $10K round on 2023-09-20, which sits far below the rest of the disclosed amounts.
The list also concentrates geographically around the Copenhagen metropolitan area: 14 of 20 entries are based in Copenhagen, Frederiksberg, or their immediate suburbs (e.g., Birkerød, Hørsholm, Hillerød, Kongens Lyngby). Temporally, activity runs from 2020-08-11 (Practio) through 2026-06-30 (Zerion Pharma), and there is a dense cluster in 2025, with multiple rounds occurring between January and May (e.g., Orbis Medicines on 2025-01-06; Cercare Medical on 2025-02-19; Dawn Health on 2025-05-05). Stage visibility is limited: 10 of 20 rows are marked “Series Unknown” and 3 are “undisclosed.”
Most recent rounds
20 shownRelated listings
Frequently asked
Which disclosed rounds look most like “headliners,” and how far above the rest do they sit?
Orbis Medicines’ $93M on 2025-01-06 is the only round above $50M, making it a clear outlier versus other disclosed rounds such as Dawn Health’s $13M (2025-05-05) and CathVision’s $9M (2023-07-18). The smallest disclosed amount is Brain+’s $10K on 2023-09-20, which is dramatically below the typical disclosed figures in the list.
Does the data over-represent the Copenhagen metro area versus other Danish locations?
Yes. 14 of 20 entries list Copenhagen, Frederiksberg, or nearby suburbs such as Hørsholm (Levvel Health ApS, 2021-08-01), Hillerød (HHC Medical, 2023-09-05), and Kongens Lyngby (Droplet IV, 2025-06-17). The remaining notable outside-Copenhagen entries include Aarhus (Ardos, 2026-05-05; Cercare Medical, 2025-02-19) and Birkerød (Zerion Pharma, 2026-06-30).
What time window contains the most entries, based on the round dates shown?
2025 is the densest stretch: multiple rounds appear from January through May, including Orbis Medicines (2025-01-06, $93M), Cercare Medical (2025-02-19, $8M), and Dawn Health (2025-05-05, $13M). The overall span runs from 2020-08-11 (Practio, $8M) to 2026-06-30 (Zerion Pharma, undisclosed).
How concentrated are round sizes within the “millions” range, and are there notable exceptions?
Several disclosed rounds cluster in the mid single-digit millions and above (e.g., Scandinavian Biolabs $4M on 2024-09-18; Woba $3M on 2023-09-01; Cercare Medical $8M on 2025-02-19). Exceptions include the $10K Brain+ entry on 2023-09-20 and the very large $93M Orbis Medicines round on 2025-01-06.
What stage labeling patterns stand out, and how does that affect comparing rounds?
Stage disclosure is incomplete: 10 of 20 rows are “Series Unknown,” and 3 of 20 are “undisclosed” amount-wise (e.g., Zerion Pharma on 2026-06-30; Ardos on 2026-05-05; TetraKit Technologies on 2025-02-17). Only a few rows show named stages like Series A (Orbis Medicines, 2025-01-06, $93M) and Seed (DARERL, 2026-03-03, $2M; Droplet IV, 2025-06-17, $2M), making cross-stage comparisons limited.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.